Literature DB >> 7049323

Vasopressin fiber pathways in the rat brain following suprachiasmatic nucleus lesioning.

E M Hoorneman, R M Buijs.   

Abstract

The contribution of the suprachiasmatic nucleus to the vasopressinergic innervation of the rat brain was determined by following the changes in the immunocytochemical localization of vasopressin-containing fibers at various intervals between 2 days and 12 weeks after bilateral lesioning of this nucleus. The disappearance of the vasopressinergic fibers makes it plausible that vasopressin-containing pathways run from the suprachiasmatic nucleus towards the periventricular nucleus, the dorsomedial nucleus of the hypothalamus and the organum vasculosum laminae terminalis. Since after lesioning the vasopressinergic fibers remained unaltered in the lateral septum, the lateral habenular nucleus, the nucleus of the amygdala, the diagonal band of Broca, the nucleus of the solitary tract, the interpeduncular nucleus and the dorsal raphe nucleus, the suprachiasmatic nucleus sends no or only minor projections to these areas. In contrast to the literature, these findings indicate that the paraventricular nucleus and possibly the supraoptic nucleus form the major source for vasopressinergic pathways in the brain.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7049323     DOI: 10.1016/0006-8993(82)90246-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  32 in total

Review 1.  Vasopressin and alcohol: a multifaceted relationship.

Authors:  Kathryn M Harper; Darin J Knapp; Hugh E Criswell; George R Breese
Journal:  Psychopharmacology (Berl)       Date:  2018-11-03       Impact factor: 4.530

2.  c-Fos expression in the brains of behaviorally "split" hamsters in constant light: calling attention to a dorsolateral region of the suprachiasmatic nucleus and the medial division of the lateral habenula.

Authors:  Mahboubeh Tavakoli-Nezhad; William J Schwartz
Journal:  J Biol Rhythms       Date:  2005-10       Impact factor: 3.182

3.  Absence of progestin receptors alters distribution of vasopressin fibers but not sexual differentiation of vasopressin system in mice.

Authors:  B D Rood; E K Murray; J Laroche; M K Yang; J D Blaustein; G J De Vries
Journal:  Neuroscience       Date:  2008-06-26       Impact factor: 3.590

Review 4.  Circadian disruption and SCN control of energy metabolism.

Authors:  Andries Kalsbeek; Frank A Scheer; Stephanie Perreau-Lenz; Susanne E La Fleur; Chun-Xia Yi; Eric Fliers; Ruud M Buijs
Journal:  FEBS Lett       Date:  2011-03-21       Impact factor: 4.124

Review 5.  Sex differences in circadian timing systems: implications for disease.

Authors:  Matthew Bailey; Rae Silver
Journal:  Front Neuroendocrinol       Date:  2013-11-25       Impact factor: 8.606

6.  Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids.

Authors:  Dawn H Loh; Catalina Abad; Christopher S Colwell; James A Waschek
Journal:  Neuroendocrinology       Date:  2008-06-19       Impact factor: 4.914

7.  Vasopressin receptor V1a regulates circadian rhythms of locomotor activity and expression of clock-controlled genes in the suprachiasmatic nuclei.

Authors:  Jia-Da Li; Katherine J Burton; Chengkang Zhang; Shuang-Bao Hu; Qun-Yong Zhou
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-03       Impact factor: 3.619

8.  Changes in hypothalamic and extra-hypothalamic vasopressin content of water-deprived rats.

Authors:  Y Epstein; M Castel; S M Glick; N Sivan; R Ravid
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

9.  Vasopressin-immunoreactive cells in the dorsomedial hypothalamic region, medial amygdaloid nucleus and locus coeruleus of the rat.

Authors:  A R Caffé; F W van Leeuwen
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

10.  Substance P in the suprachiasmatic nucleus of the rat: an immunohistochemical and in situ hybridization study.

Authors:  J D Mikkelsen; P J Larsen
Journal:  Histochemistry       Date:  1993-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.